26.04.2006 11:02:00
|
Longs Drug Stores Announces Karen Stout Executive Vice President and Chief Operating Officer
WALNUT CREEK, Calif., April 26 /PRNewswire-FirstCall/ -- Longs Drug Stores Corporation today announced that Karen Stout has been named Executive Vice President and Chief Operating Officer, effective May 15, 2006. Reporting directly to Warren F. Bryant, Chairman, President and Chief Executive Officer, Stout will be responsible for store operations, marketing, merchandising, construction and loss prevention at Longs Drugs.
Stout has more than 27 years of retail experience. Immediately prior to joining Longs Drugs, Stout served as Executive Vice President, Merchandising for BJ's Wholesale Club, Inc. Prior to her most recent position, Stout was President of two divisions of the Atlantic & Pacific Tea Company. From 1978 to 2000, Stout was employed by Harris Teeter Supermarkets, Inc., where she advanced through a succession of management positions, rising to Senior Vice President, Operations in 1997. Stout earned a Bachelor's degree from the University of North Carolina and an MBA from Queens College.
About Longs Drug Stores
Headquartered in Walnut Creek, California, Longs Drug Stores Corporation is one of the most recognized retail drug store chains on the West Coast and in Hawaii. With 477 stores, Longs Drugs provide expert pharmacy services and a wide assortment of merchandise focusing on health, wellness, beauty and convenience. Longs also provides pharmacy benefit management services and Medicare beneficiary prescription drug plans through its wholly-owned subsidiary, RxAmerica, LLC. Additional information about Longs and its services is available at http://www.longs.com/ and more information about RxAmerica is available at http://www.rxamerica.com/.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu CVS Health Corpmehr Nachrichten
24.01.25 |
S&P 500-Titel CVS Health-Aktie: So viel Verlust hätte eine CVS Health-Investition von vor 10 Jahren eingebracht (finanzen.at) | |
17.01.25 |
S&P 500-Titel CVS Health-Aktie: So viel Verlust hätte ein Investment in CVS Health von vor 5 Jahren bedeutet (finanzen.at) | |
13.01.25 |
Pluszeichen in New York: S&P 500 zum Handelsende fester (finanzen.at) | |
13.01.25 |
Schwache Performance in New York: S&P 500 zeigt sich schwächer (finanzen.at) | |
13.01.25 |
Börse New York in Rot: So steht der S&P 500 am Montagmittag (finanzen.at) | |
13.01.25 |
NYSE-Handel S&P 500 verbucht zum Start des Montagshandels Abschläge (finanzen.at) | |
10.01.25 |
Minuszeichen in New York: S&P 500 präsentiert sich schlussendlich schwächer (finanzen.at) | |
10.01.25 |
S&P 500-Handel aktuell: S&P 500 notiert am Freitagnachmittag im Minus (finanzen.at) |
Analysen zu CVS Health Corpmehr Analysen
Aktien in diesem Artikel
CVS Health Corp | 51,60 | 0,60% |
Indizes in diesem Artikel
S&P 600 SmallCap | 935,46 | -0,94% |